REFERENCES
- De Leval X, Julemont F, Benoit V, Frederich M, Pirotte B, Dogne J M. First and second generations of COX-2 selective inhibitors. Mini Rev Med Chem 2004; 4: 597–601, [PUBMED], [INFOTRIEVE], [CSA]
- Stephens J, Laskin B, Pashos C, Pena B, Wong J. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors. Rheumatology 2003; 42(Suppl 3)iii40–iii52, [PUBMED], [INFOTRIEVE], [CSA]
- Kismet K, Akay M T, Abbasoglu O, Ercan A. Celecoxib: A potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 2004; 28: 127–142, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Malhotra S, Shafiq N, Pandhi P. COX-2 inhibitors: A CLASS act or just VIGORously promoted. MedGenMed 2004; 6: 6, [PUBMED], [INFOTRIEVE], [CSA]
- Whelton A. COX-2-specific inhibitors and the kidney: Effect on hypertension and oedema. J Hypertens Suppl 2002; 20: S31–S35, [PUBMED], [INFOTRIEVE], [CSA]
- Rossat J, Maillard M, Nussberger J, Brunner H R, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999; 66: 76–84, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bing R J. Cyclooxygenase-2 inhibitors: Is there an association with coronary or renal events?. Curr Atheroscler Rep 2003; 5: 114–117, [PUBMED], [INFOTRIEVE], [CSA]
- Giovanni G, Giovanni P. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?. J Nephrol 2002; 15: 480–488, [PUBMED], [INFOTRIEVE], [CSA]
- Henao J, Hisamuddin I, Nzerue C M, Vasandani G, Hewan-Lowe K. Celecoxib-induced acute interstitial nephritis. Am J Kidney Dis 2002; 39: 1313–1317, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bootman M D, Berridge M J, Lipp P. Cooking with calcium: The recipes for composing global signals from elementary events. Cell 1993; 91: 367–373, [CROSSREF], [CSA]
- Brini M, Carafoli E. Calcium signalling: A historical account, recent developments and future perspectives. Cell Mol Life Sci 2000; 57: 354–370, [PUBMED], [INFOTRIEVE], [CSA]
- Clapham D E. Calcium signaling. Cell 1995; 80: 259–268, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wang J L, Lin K L, Chen J S, Lu Y C, Jiann B P, Chang H T, Hsu S S, Chen W C, Huang J K, Ho C M, Jan C R. Effect of celecoxib on Ca2 + movement and cell proliferation in human osteoblasts. Biochem Pharmacol 2004; 67: 1123–1130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Johnson A J, Hsu A L, Lin H P, Song X, Chen C S. The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: A plausible link with its anti-tumor effect and cardiovascular risks. Biochem J 2002; 366(Pt 3)831–837, [PUBMED], [INFOTRIEVE], [CSA]
- Jan C R, Ho C M, Wu S N, Huang J K, Tseng C J. Mechanism of lanthanum inhibition of extracellular ATP-evoked calcium mobilization in MDCK cells. Life Sci 1998; 62: 533–540, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jan C R, Ho C M, Wu S N, Tseng C J. Bradykinin-evoked Ca2 + mobilization in Madin Darby canine kidney cells. Eur J Pharmacol 1998; 355: 219–233, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yeh J H, Chung H M, Ho C M, Jan C R. Mercury-induced Ca2 + increase and cytotoxicity in renal tubular cells. Life Sci 2004; 74: 2075–2083, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hsu S S, Chen W C, Jiann B P, Chen J S, Huang J K, Chang H T, Cheng H H, Lo Y K, Ho C M, Jan C R. Effect of the antidepressant maprotiline on calcium movement and the viability of renal tubular cells. Arch Toxicol 2004; 78: 453–459, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Putney J W. Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986; 7: 1–12, [CSA]
- Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2 + indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450, [PUBMED], [INFOTRIEVE], [CSA]
- Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19: 1518–1520, [PUBMED], [INFOTRIEVE], [CSA]
- Merritt J E, Jacob R, Hallam T J. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989; 264: 1522–1527, [PUBMED], [INFOTRIEVE], [CSA]
- Thastrup O, Cullen P T, Drobak B K, Hanley M R, Dawson A P. Thapsigargin, a tumor promoter, discharges intracellular Ca2 + stores by specific inhibition of the endoplasmic reticulum Ca2 +-ATPase. Proc Natl Acad Sci USA 1990; 87: 2466–2470, [PUBMED], [INFOTRIEVE], [CSA]
- Thompson A K, Mostafapour S P, Denlinger L C, Bleasdale J E, Fisher S K. The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 1991; 266: 23856–23862, [PUBMED], [INFOTRIEVE], [CSA]
- McFadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol 2002; 135: 1–13, [PUBMED], [INFOTRIEVE], [CSA]
- Peng J B, Brown E M, Hediger M A. Epithelial Ca2 + entry channels: Transcellular Ca2 + transport and beyond. J Physiol 2003; 551(Pt 3)729–740, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Williams C S, Watson A J, Sheng H, Helou R, Shao J, Du Bois R N. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models. Cancer Res 2002; 60: 6045–6051, [CSA]
- Liu X, Yue P, Zhou Z, Khuri F R, Sun S Y. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004; 96: 1769–1780, [PUBMED], [INFOTRIEVE], [CSA]
- Basu G D, Pathangey L B, Tinder T L, Lagioia M, Gendler S J, Mukherjee P. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res 2004; 2: 632–642, [PUBMED], [INFOTRIEVE], [CSA]
- Stempak D, Gammon J, Klein J, Koren G, Baruchel S. Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther 2002; 72: 490–497, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]